A man in Miami allegedly filed $38 million in false and fraudulent claims related to infusions of infliximab, also known by the brand name Remicade.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}